We next determined the expression of RRM2, CDC6, and TOP2A mRNA and protein in XBP1-knockout sub-clones of MCF7 cells and ER-positive (MCF7, T47D, and BT474) breast cancer cells after treatment with STF083010. Here, RRM2 is linked to breast cancer.